This study aims to understand what causes hemorrhagic stroke (bleeding in the brain). Researchers are looking at your genes and other factors to find out why some people get this type of stroke. They will be studying a specific area of DNA on chromosome 1q22 to see if changes in this area affect your risk of stroke. The goal is to identify these risk factors to help develop better treatments in the future. You may be able to join if you are 18 or older, have had a spontaneous hemorrhagic stroke, and live near the study center. The study is ongoing and plans to enroll 1000 participants.

Study design

This is an observational study, meaning researchers will observe participants without providing any interventions. It aims to enroll 1000 participants.

What's involved

You would need to provide consent for an interview, blood pressure measurements, and DNA sampling. The record does not specify the number of visits or the duration of participation.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, deep DNA sequencing, is ongoing and planned to be completed by the end of June 2021. Further follow-up details are not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.